Antibiotic resistance in Helicobacter pylori: a genetic and physiological perspective
Open Access
- 23 May 2025
- journal article
- review article
- Published by Springer Nature in Gut Pathogens
- Vol. 17 (1) , 1-20
Abstract
The identification of Helicobacter pylori (H. pylori) infection as the primary etiology of gastroduodenal diseases represents a significant advancement in the field of gastroenterology. The management of these diseases has undergone a substantial transformation, and antibiotic treatment is now universally applicable. H. pylori has been the subject of numerous investigations to determine the prevalence of antibiotic resistance. However, many of these studies are limited, particularly regarding the number and representativeness of the strains assessed. Genetic and physiological modifications, such as gene mutations, efflux pump alterations, biofilm formation, and coccoid formation, contribute to the observed resistance. Our review focuses on the emergence of antibiotic-resistant strains, particularly emphasizing the various modifications of H. pylori that confer this resistance. In conclusion, we elucidate the challenges, potential solutions, and prospects in this field, providing researchers with the knowledge necessary to overcome the resistance exhibited by H. pylori.Keywords
Funding Information
- Sichuan Provincial Science and Technology Support Program (2023NSFSC0586, 2023NSFSC0586)
- Natural Science Foundation of Sichuan University of Science and Engineering (2021RC29)
This publication has 225 references indexed in Scilit:
- The complete genome sequence of the gastric pathogen Helicobacter pyloriNature, 1997
- Changes in Helicobacter pylori ultrastructure and antigens during conversion from the bacillary to the coccoid formInfection and Immunity, 1996
- Bactericidal and morphological effects of amoxicillin on Helicobacter pyloriAntimicrobial Agents and Chemotherapy, 1995
- Role of efflux pump(s) in intrinsic resistance of Pseudomonas aeruginosa: resistance to tetracycline, chloramphenicol, and norfloxacinAntimicrobial Agents and Chemotherapy, 1994
- Molecular cloning and characterization of acrA and acrE genes of Escherichia coliJournal of Bacteriology, 1993
- The coccoid forms ofHelicobacter pylori. Criteria for their viabilityEpidemiology and Infection, 1993
- Coccoid like forms (CLF) of Helicobacter pylori. Enzyme activity and antigenicityZentralblatt für Bakteriologie, 1993
- Protection by human milk IgA against Helicobacter pylori infection in infancyThe Lancet, 1993
- Effect of physical environment on survival of Helicobacter pylori.Journal of Clinical Pathology, 1992
- Rifabutin (Ansamycin LM 427): A New Rifamycin-S Derivative for the Treatment of Mycobacterial DiseasesClinical Infectious Diseases, 1987